Dulcey Ann Kingett, PT | |
515 Kirkland Way, Kirkland, WA 98033-6219 | |
(425) 765-3717 | |
Not Available |
Full Name | Dulcey Ann Kingett |
---|---|
Gender | Female |
Speciality | Physical Therapist |
Location | 515 Kirkland Way, Kirkland, Washington |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1609487917 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208100000X | Physical Medicine & Rehabilitation | P160047655 (Washington) | Secondary |
225100000X | Physical Therapist | 60047655 (Washington) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dulcey Ann Kingett, PT 221 Wells Ave N, Renton, WA 98057-5612 Ph: () - | Dulcey Ann Kingett, PT 515 Kirkland Way, Kirkland, WA 98033-6219 Ph: (425) 765-3717 |
News Archive
The opportunistic fungal pathogen Candida albicans inconspicuously lives in our bodies until it senses that we are weak, when it quickly adapts to go on the offensive. The fungus, known for causing yeast and other minor infections, also causes a sometimes-fatal infection known as candidemia in immunocompromised patients. An in vivo study, published in mBio, demonstrates how C. albicans can distinguish between a healthy and an unhealthy host and alter its physiology to attack.
HHS Secretary Mike Leavitt on Monday discussed the details of an electronic prescribing incentive program scheduled to begin on Jan. 1, 2009, that will increase Medicare payments to physicians who adopt the technology, the AP/Chicago Tribune reports.
An exciting new study published in the journal Nature Biomedical Engineering in April 2020 reports excellent results with a new test for two common viruses that infect kidney transplant patients. The levels of these viruses shoot up during the acute phase of rejection.
Integration with a picture archiving and communication system (PACS) improves radiologists' use of clinical decision support tools, according to a study in the July issue of the Journal of the American College of Radiology.
A lower dose of zoledronic acid than currently recommended for prevention of bone fractures due to osteoporosis decreases bone resorption and increases bone density, and may be effective in reducing the risk of osteoporotic fractures, a study finds.
› Verified 3 days ago